BICO Group Dirección

Dirección controles de criterios 2/4

El CEO de BICO Group's es Maria Forss , nombrado en Nov 2023, tiene una permanencia de menos de un año. compensación anual total es SEK7.43M, compuesta por 6.5% salario y 93.5% primas, incluidas acciones y opciones de la empresa. posee directamente un 0.04% de las acciones de la empresa, por valor de $114.76K. La antigüedad media del equipo directivo y de la junta directiva es de 1.2 años y 3.7 años, respectivamente.

Información clave

Maria Forss

Chief Executive Officer (CEO)

kr7.4m

Compensación total

Porcentaje del salario del CEO	6.5%
Permanencia del CEO	less than a year
Participación del CEO	0.06%
Permanencia media de la dirección	1.3yrs
Promedio de permanencia en la Junta Directiva	3.8yrs

Actualizaciones recientes de la dirección

Recent updates

Análisis de compensación del CEO

¿Cómo ha cambiado la remuneración de Maria Forss en comparación con los beneficios de BICO Group?
Fecha	Compensación total	Salario	Ingresos de la empresa
Mar 31 2024	n/a	n/a	-kr2b
Dec 31 2023	kr7m	kr484k	-kr2b

Compensación vs. Mercado: La compensación total de Maria($USD682.12K) está por debajo de la media de empresas de tamaño similar en el mercado US ($USD1.63M).

Compensación vs. Ingresos: Datos insuficientes para comparar la compensación de Maria con los resultados de la empresa.

CEO

Maria Forss (51 yo)

less than a year

Permanencia

kr7,425,520

Compensación

Ms. Maria Forss serves as President & CEO of BICO Group AB (publ) since November 20, 2023. She served as Senior Vice President of Consumables at Vitrolife AB (publ) since January 01, 2022 until August 2023...

Equipo directivo

Nombre	Posición	Permanencia	Compensación	Propiedad
Maria Forss	President & CEO	less than a year	kr7.43m	0.057% SEK 166.4k
Jacob Thordenberg	Group Chief Financial Officer	1.3yrs	sin datos	0.026% SEK 76.5k
Marius Balger	Chief Operating Officer	1.2yrs	sin datos	sin datos
Asa Hillsten	Senior VP & Head of Investor Relations	no data	sin datos	sin datos
Lotta Bus	SVP, General Counsel	4.3yrs	sin datos	0.0099% SEK 29.1k
Artur Aira	Head of Corporate Development and M&A	1.2yrs	kr150.00k	0% SEK 0
Catharina Nordlund	Global Head of Human Resources	less than a year	sin datos	sin datos
Itedale Redwan	Chief Scientific Officer - Bioprinting	no data	sin datos	sin datos
Niclas Emanuelsson	Head of Global Operations	4.3yrs	sin datos	sin datos
Holger Eickhoff	Senior VP & Business Area Director - Bioautomation	2.3yrs	sin datos	sin datos
Erica Bell	Senior VP & Chief People Officer	no data	sin datos	sin datos
Nicolas Gabriel-Robez	Chief Security Officer	no data	sin datos	sin datos

1.3yrs

Permanencia media

51yo

Promedio de edad

Equipo directivo experimentado: El equipo directivo de CLLK.F no se considera experimentado ( 1.2 años antigüedad media), lo que sugiere un nuevo equipo.

Miembros de la Junta

Nombre	Posición	Permanencia	Compensación	Propiedad
Rolf Classon	Independent Chairman of the Board	2.1yrs	kr650.00k	0.044% SEK 128.8k
Christian Wildmoser	Independent Director	4.4yrs	kr285.00k	0.45% SEK 1.3m
Robert Langer	Member of Scientific Advisory Board	3.5yrs	sin datos	sin datos
Helena Skantorp	Independent Director	4.4yrs	kr350.00k	0.0057% SEK 16.6k
Ulrika Dellby	Independent Deputy Chairwoman	2.1yrs	kr510.00k	0.027% SEK 78.9k
Bengt Sjoholm	Independent Director	8.3yrs	kr285.00k	0.49% SEK 1.4m
Susan Tousi	Independent Director	2.5yrs	kr250.00k	sin datos
Ali Khademhosseini	Member of Scientific Advisory Board	7.2yrs	sin datos	sin datos
Ido Amit	Member of Scientific Advisory Board	3.8yrs	sin datos	sin datos

3.8yrs

Permanencia media

68yo

Promedio de edad

Junta con experiencia: La junta directiva de CLLK.F se considera experimentada (3.7 años de antigüedad promedio).

BICO Group Dirección

Dirección controles de criterios 2/4

Información clave

Actualizaciones recientes de la dirección

BICO Group AB (publ) Elects Alexandra Gatzemeyer as Member of the Board of Directors

BICO Group AB (publ) Announces the Appointment of Anders Fogelberg as Chief Commercial Officer, Effective June 13, 2024

BICO Group AB (publ) Announces Gerry Mackay and Erik Gatenholm Decline Re-Election of the Board of Directors

BICO Group AB (publ) Appoints Catharina Nordlund as Global Head of HR

BICO Group AB (publ) Announces Chief Executive Officer Changes

BICO Group AB (publ) Elects Gerry Mackay to Its Board of Directors

Recent updates

BICO Group AB (publ) Elects Alexandra Gatzemeyer as Member of the Board of Directors

BICO Group AB (publ) Announces the Appointment of Anders Fogelberg as Chief Commercial Officer, Effective June 13, 2024

BICO Group AB (publ) Announces Gerry Mackay and Erik Gatenholm Decline Re-Election of the Board of Directors

BICO Group AB (publ) to Report Fiscal Year 2024 Results on Feb 19, 2025

BICO Group AB (publ) to Report Q3, 2024 Results on Nov 13, 2024

BICO Group AB (publ) Appoints Catharina Nordlund as Global Head of HR

BICO Group AB (publ) to Report Fiscal Year 2023 Results on Mar 15, 2024

BICO Group AB (publ) Announces Chief Executive Officer Changes

Beos Light Industrial Germany 1 Fund, a fund managed by BEOS AG agreed to acquire property on Wagner-Régeny-Straße 15 from BICO Group AB (publ) (OM:BICO) for €21 million.

BICO Group AB (publ) Elects Gerry Mackay to Its Board of Directors

BICO Group AB (publ) to Report Fiscal Year 2023 Results on Feb 20, 2024

BICO Group AB Appoints Marius Balger as Chief Operating Officer, Effective March 1, 2023

BICO Group AB Announces the Appointment of Jacob Thordenberg as Group CFO

BICO Group AB (publ) to Report Q1, 2023 Results on May 04, 2023

BICO Group AB (publ) to Report Q2, 2023 Results on Jul 20, 2023

BICO Group Announces Appointment of Nomination Committee 2023

BICO Group AB (publ) to Report Fiscal Year 2023 Results on Feb 22, 2023

BICO Group Adds Åsa Hillsten as SVP and Head of IR

BICO Group AB (publ) (OM : BICO) acquired Allegro 3D for $11 million.

BICO (publ) Appoints Mikael Engblom as Interim CFO

BICO Group AB (Publ) Announces Board Appointments

BICO Reaches Beneficial and Sustainable Solution with Organovo

DISPENDIX, A BICO Company, Announces That the I.DOT HT Non-contact Dispenser and the L.DROP Liquid Handler will be introduced at SLAS 2022

BICO Group AB Announces Statement Regarding Counterclaims in Patent Lawsuit by Organovo Against Cellink

BICO Group AB (publ) (OM:BICO) agreed to acquire Biosero Llc.

BICO Group AB (publ) (OM:BICO) acquired all outstanding shares in Advanced BioMatrix, Inc. for $18 million.

CELLINK Receives Patent for Robotic Systems for Personalized and Automated Aesthetic Medical Procedures

Cellink AB (publ) (OM:CLNK B) completed the acquisition of Discover Echo Inc.

Cellink AB (publ) (OM:CLNK B) completed the acquisition of Nanoscribe GmbH for approximately €37 million.

Cellink AB (publ) (OM:CLNK B) entered into an agreement to acquire Nanoscribe GmbH for €34 million.

Cellink AB (publ) (OM:CLNK B) entered into an agreement to acquire MatTek Corporation for $68 million.

Cellink AB (publ) (OM:CLNK B) completed the acquisition of Ginolis Ltd from Verso Fund II of Verso Capital Oy, Finnvera plc and Innovestor Ventures for €65.7 million.

Cellink AB (publ) to Report Fiscal Year 2021 Results on Mar 16, 2022

Cellink AB (publ) (OM:CLNK B) entered into an agreement to acquire Ginolis Ltd for €70 million.

Cellink AB (publ) Announces Distribution Agreement Including New Products for Single-Cell RNA Sequencing and NGS Library Preparation

Cellink Announces Third Year Extension of Collaboration with A Global Biopharmaceutical Company for Drug Discovery

Cellink and Phasefocus Announces a Partnership to Bring Livecyte High Content Live Cell Imager to a Wider Audience

Cellink AB (publ) Elects Aristotelis Nastos as Member of the Board of Directors

CELLINK and Atelerix Team Up to Enable the Shipping At Room Temperature of Fragile 3D Bioprinted Constructs by the World's Bioprinting Community

CELLINK to Help Develop 3D Bioprinted Personalised Scaffolds for Tissue Regeneration of Ankle Joint S as Part of the Triankle Project

Cellink AB (publ) to Report Second Half, 2020 Results on Oct 22, 2020

Cellink AB (Publ) Announces Leaving Board of Directors for an Operational Role as Business Area Manager for the Bioprinting Business Unit

Cellink AB (publ) (OM:CLNK B) completed the acquisition of SCIENION AG from NRW.Bank Venture Fonds, L.P., managed by NRW.Bank, Investment Arm and other shareholders.

Cellink AB (publ) has completed a Follow-on Equity Offering in the amount of SEK 945.99632 million.

Análisis de compensación del CEO

CEO

Permanencia

Compensación

Equipo directivo

Permanencia media

Promedio de edad

Miembros de la Junta

Permanencia media

Promedio de edad